![David J. Lockhart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David J. Lockhart
Inga fler pågående positioner
Profil
David J.
Lockhart was the founder of Ambit Biosciences Corp., founded in 2001, where the title held was President & Chief Scientific Officer in 2005.
Former jobs include Director-Genomics at Novartis Institute for Functional Genomics, Inc. from 1999 to 2000, Director & Chief Scientific Officer at ReCode Therapeutics, Inc. from 2022 to 2025, Vice President-Genomics Research at Affymetrix, Inc., and Chief Scientific Officer at Amicus Therapeutics, Inc. from 2006 to 2013.
Education includes a doctorate from Stanford University conferred in 1990.
Tidigare kända positioner av David J. Lockhart
| Företag | Position | Slut |
|---|---|---|
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage genetic medicines company that develops therapeutics for genetically defined diseases | Verkställande Direktör | 2022-01-11 |
| AMICUS THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2013-12-31 |
| AMBIT BIOSCIENCES CORP | Grundare | 2005-07-01 |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Företagsledare/Principal | 2000-07-01 |
Transcriptx, Inc.
 Transcriptx, Inc. BiotechnologyHealth Technology Develops mRNA therapies intended to treat primary ciliary dyskinesia | Verkställande Direktör | - |
David J. Lockharts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
94
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage genetic medicines company that develops therapeutics for genetically defined diseases | Health Technology |
Transcriptx, Inc.
Transcriptx, Inc. BiotechnologyHealth Technology Develops mRNA therapies intended to treat primary ciliary dyskinesia | Health Technology |
